CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors

PR Newswire
December 21, 2023 — 01:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: bank biotech car Education Hangzhou healthcare medicine technology University zhejiang

Related News:

Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

May 2, 2024 — 07:01

MGM China Reports 2024 First Quarter Results

May 2, 2024 — 06:16

Chinese president’s upcoming visit to bring new hope to Serbia’s development: Vucic

May 1, 2024 — 11:51

GoDaddy: Six Tips for building a website that really works for your business

May 1, 2024 — 01:22

LYB to build integrated plastic waste recycling hub in Knapsack

April 29, 2024 — 19:00

Every Dollar Lost to Fraud in Australia Costs Firms AUD$3.68 According to LexisNexis True Cost of Fraud Study

April 29, 2024 — 07:00

CATL and Beijing Hyundai sign strategic agreement on EV batteries

April 28, 2024 — 11:10

Global Times: CNNC provides nuclear energy solutions for global energy transition

April 28, 2024 — 10:49

Galaxy Macau, The World Class Integrated Resort, Unveils the "Experience Macao Singapore Roadshow"

April 27, 2024 — 15:06